LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Faran Shimi Pharmaceutical
03 1Temad Co
04 1Rusan Pharma
05 1Medichem S.A
06 1Noramco
07 1CHONGQING LAND TOWER PHARMACEUTICAL CO
08 1Fujifilm Diosynth Biotechnologies
09 1Hasti Aria Shimi
10 1Mallinckrodt Pharmaceuticals
11 1Merck & Co
12 1OmnisMed Pharmaceuticals
13 1Saintsun Pharma
14 1Saneca Pharmaceuticals
15 1Siegfried AG
16 1Tasmanian Alkaloids Pty Ltd
17 1Tecoland Corporation
01 1Australia
02 2China
03 1India
04 3Iran
05 1Ireland
06 1Slovakia
07 1Spain
08 1Switzerland
09 4U.S.A
10 2United Kingdom
01 4Active
02 3Inactive
03 10Blank
01 17Blank
01 17Blank
01 1WC-0278
02 16Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Date of Issue : 2021-08-27
Valid Till : 2024-06-10
Written Confirmation Number : WC-0278
Address of the Firm :
NDC Package Code : 70312-0888
Start Marketing Date : 2018-01-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-04-23
Pay. Date : 2016-04-07
DMF Number : 22992
Submission : 2009-07-28
Status : Active
Type : II
NDC Package Code : 51634-1060
Start Marketing Date : 2024-03-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-01-12
Pay. Date : 2015-09-22
DMF Number : 29619
Submission : 2015-09-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31691
Submission : 2017-07-25
Status : Active
Type : II
NDC Package Code : 82105-003
Start Marketing Date : 2023-07-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12349
Submission : 1997-02-05
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15221
Submission : 2001-01-03
Status : Inactive
Type : II
A Naltrexone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naltrexone, including repackagers and relabelers. The FDA regulates Naltrexone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naltrexone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Naltrexone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Naltrexone supplier is an individual or a company that provides Naltrexone active pharmaceutical ingredient (API) or Naltrexone finished formulations upon request. The Naltrexone suppliers may include Naltrexone API manufacturers, exporters, distributors and traders.
click here to find a list of Naltrexone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 17 companies offering Naltrexone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?